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Background. Clostridium botulinum and related clostridial species express extremely potent neurotoxins known as botulinum
neurotoxins (BoNTs) that cause long-lasting, potentially fatal intoxications in humans and other mammals. The amino acid
variation within the BoNT is used to categorize the species into seven immunologically distinct BoNT serotypes (A–G) which are
further divided into subtypes. The BoNTs are located within two generally conserved gene arrangements known as botulinum
progenitor complexes which encode toxin-associated proteins involved in toxin stability and expression. Methodology/
Principal Findings. Because serotype A and B strains are responsible for the vast majority of human botulism cases
worldwide, the location, arrangement and sequences of genes from eight different toxin complexes representing four different
BoNT/A subtypes (BoNT/A1-Ba4) and one BoNT/B1 strain were examined. The bivalent Ba4 strain contained both the BoNT/A4
and BoNT/bvB toxin clusters. The arrangements of the BoNT/A3 and BoNT/A4 subtypes differed from the BoNT/A1 strains and
were similar to those of BoNT/A2. However, unlike the BoNT/A2 subtype, the toxin complex genes of BoNT/A3 and BoNT/A4
were found within large plasmids and not within the chromosome. In the Ba4 strain, both BoNT toxin clusters (A4 and bivalent
B) were located within the same 270 kb plasmid, separated by 97 kb. Complete genomic sequencing of the BoNT/B1 strain also
revealed that its toxin complex genes were located within a 149 kb plasmid and the BoNT/A3 complex is within a 267 kb
plasmid. Conclusions/Significance. Despite their size differences and the BoNT genes they contain, the three plasmids
containing these toxin cluster genes share significant sequence identity. The presence of partial insertion sequence (IS)
elements, evidence of recombination/gene duplication events, and the discovery of the BoNT/A3, BoNT/Ba4 and BoNT/B1 toxin
complex genes within plasmids illustrate the different mechanisms by which these genes move among diverse genetic
backgrounds of C. botulinum.
Citation: Smith TJ, Hill KK, Foley BT, Detter JC, Munk AC, et al (2007) Analysis of the Neurotoxin Complex Genes in Clostridium botulinum A1-A4 and
B1 Strains: BoNT/A3, /Ba4 and /B1 Clusters Are Located within Plasmids. PLoS ONE 2(12): e1271. doi:10.1371/journal.pone.0001271
INTRODUCTION
Clostridium botulinum is a taxonomic collection of several distinct
species of anaerobic gram positive spore-forming bacteria which
produce the most poisonous naturally occurring substance known,
botulinum neurotoxin (BoNT) [1]. The organisms have been
divided into four distinct genetic and physiological groupings [2]
and 16s rDNA sequencing has shown these groupings to be
separate species [3,4]. The neurotoxins produced by these
organisms are categorized serologically into seven distinct groups
designated serotype A through G [2]. Four of the seven serotypes,
A, B, E, and F, cause human botulism with the vast majority of
cases due to serotypes A and B [5].
The neurotoxins cause the disease botulism, a rare but
potentially fatal intoxication that occurs in three forms: foodborne
botulism, infant botulism, and wound botulism. Intoxications are
long-lived, persisting from several weeks to several months, and
victims may require intensive care, including mechanical ventila-
tion, for extended periods of time [6]. Because of their extreme
toxicity and prolonged effects, botulinum neurotoxins are grouped
as CDC category A select agents [7]. In contrast, this extremely
toxic protein has been employed to treat a wide variety of muscle
and nerve disorders, including arthritis and migraine headaches
[8].
C. botulinum strains, and the neurotoxins they produce, are highly
diverse. Subtypes have been identified within six of the seven
serotypes based on amino acid variation within the BoNT. While
serotypes differ by about 35–70%, subtype differences range from
approximately 2–32%. This diversity can account for significant
differences in protection with vaccines and therapeutic agents [9,10].
Although less common, bivalent strains that express two different
BoNT types exist and are designated by the predominant toxin
produced (Ab, Ba, Af, Bf) [11]. Other bivalent strain variants such as
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the A1(B) strains contain both BoNT/A and BoNT/B genes but
express only BoNT/A [12]. In addition to the variation within C.
botulinum, BoNTs found in other species such as C. baratii (BoNT/F)
and C. butyricum (BoNT/E) have resulted in disease[5].
The BoNT is associated with several proteins in arrangements
known as botulinum progenitor neurotoxin gene clusters. The
botulinum progenitor neurotoxin gene clusters are approximately
11–14 kb and encode for 3–7 proteins that form the neurotoxin
complex. All toxin clusters contain a nontoxin-nonhemagglutinin
(NTNH) protein that is closely associated with the BoNT protein.
Some toxin clusters have associated HA proteins with hemagglu-
tinating properties, while others lack these proteins. One of the
proteins, BotR, is known to be a regulatory protein that controls
the expression of several of the other toxin cluster proteins [13].
The functions of the associated nontoxic proteins are not fully
understood but it is thought that these proteins assist in stability of
the neurotoxin within the acidic and protease-rich environment of
the stomach and assist in transport of the toxin from the intestinal
area to the bloodstream [14].
The arrangement and sequence of these toxin complex genes in
relation to the BoNT gene has been described for all seven serotypes
and for several subtypes within these serotypes. Serotype A subtypes
exhibit two different toxin complex gene arrangements. The BoNT/
A1 subtype contains polycistronic hemagglutinins HA70, HA17,
HA33, and BotR, NTNH and BoNT genes [15]. This same
arrangement is also found in strains of serotype B [16,17] and is
similar to the arrangement within serotype G [18] and C and D
strains [19,20]. In contrast, the BoNT/A2 subtype toxin gene cluster
contains polycistronic open reading frames orfX3, orfX2, orfX1, and
BotR, p47, NTNH, and BoNT genes [21]. This arrangement has
also been described in serotype F strains [17,22] and the A1
neurotoxin cluster from A1(B) strains [15]. A similar arrangement,
but lacking the BotR gene, is found within C. botulinum type E and
BoNT/E-producing C. butyricum strains [23].
Although the overall arrangement of the BoNT complex genes
within the different serotypes is similar, the DNA and amino acid
sequences within these genes can differ greatly from each other.
Differences among serotypes [24], among subtypes within a serotype
[23], and within a subtype [25] have all been described. For
example, the toxin complex genes of BoNT/A1 and BoNT/C both
contain HA70, HA17, HA33, BotR, NTNH and BoNT. However,
comparisons of the amino acid identities for these proteins show they
range from only 29%–67% [15,19]. In contrast, the amino acid
identities for the toxin cluster within BoNT/A1 and BoNT/B1
subtypes are quite high (82%–98%) for all non-toxin cluster proteins
but surprisingly low (37%) for the toxin [15,26]. The BoNT proteins
are particularly divergent, with amino acid homologies for the BoNT
serotypes ranging from 34–64% [19]. In contrast, NTNH amino
acid homologies from all seven serotypes range from 58%–100%,
illustrating the conserved nature of this protein [18].
Comparisons among the genes within the toxin cluster provide
an insight into the relationships of the different serotypes and
identify regions of genetic recombination and sequence conserva-
tion. To further understand the relationships of the toxin cluster
genes in serotype A and B strains, whole genome sequencing of
several C. botulinum strains were undertaken. Sequences represent-
ing the four different BoNT/A subtypes (BoNT/A1-A4), including
a bivalent Ba4 strain that produces both bivalent BoNT/B and
BoNT/A4, and one BoNT/B1 strain were analyzed and
compared with the published sequence from BoNT/A1 strain
ATCC 3502 (Hall 174) [4]. The similarity of these BoNT/A1-A4
and BoNT/B1 complex genes to each other, their intergenic
regions and flanking regions, and their location within the genome
or within a plasmid is presented.
MATERIALS AND METHODS
Strains
A total of six strains representing the four different subtypes of
BoNT/A (BoNT/A1-A4), and a BoNT/B1 were selected for
genomic sequencing. These included two BoNT/A1 strains (Hall
and ATCC 19397), the BoNT/A2 Kyoto-F strain, the BoNT/A3
Loch Maree strain, a bivalent Ba4 strain (strain 657) and a BoNT/
B1-producing strain (okra). The histories of the two BoNT/A1
strains are unknown but most likely originated from foodborne
botulism cases in the western US. The Kyoto-F strain was associated
with an infant botulism case in Japan [27]. The Loch Maree strain
was isolated from a food poisoning incident in Scotland [28]. The
bivalent Ba4 strain (657) was from an infant botulism case in Texas
[29]. The BoNT/B1 okra strain was originally obtained from the
National Institute of Health [26] and is presumed to be from
a foodborne botulism incident in the US. Additional details about
these strains have been published previously [30].
DNA cloning
DNA from each strain was isolated as previously described [30].
Isolated DNA was randomly sheared to 2–3 or 6–8 kb fragments
using a HydroShearTM (Genomic Solutions, Ann Arbor, MI). The
sheared DNA was blunt-end repaired, separated on an agarose
gel, and extracted and purified using QIAquickTM Gel Extraction
Kit (Qiagen, Valencia, CA). Purified fragments were ligated into
the Sma I site of pUC 18 (Roche, Pleasanton, CA) and
electroporated into DH10B ElectromaxTM cells (Invitrogen Corp.,
Carlsbad, CA). Transformed cells were selected from LB agar
plates containing 100 mg/ml of ampicillin, 120 mg/ml of IPTG,
and 50 mg/ml of X-GAL. Recombinant colonies were used to
inoculate 384-well microtiter plates for plasmid amplification.
E. coli cultures were amplified by rolling circle amplification
(RCA) using the TempliphiTM DNA Sequencing Template
Amplification Kit (GE Healthcare, Piscataway, NJ). The amplified
plasmids were sequenced with standard M13 228 or 240 primers
using the BigDye sequencing kit (Applied Biosystems Inc., Foster
City, CA). The reactions were purified by a magnetic bead
protocol (see research protocols, ,http://www.jgi.doe.gov) and
run on an ABI PRISM 3730xl capillary DNA sequencer (Applied
Biosystems Inc. Foster City, CA).
Sequences were assembled with parallel phrap (High Perfor-
mance Software, LLC). Possible mis-assemblies were corrected
with Dupfinisher [31] or by analysis of transposon insertions in
bridge clones. Gaps between contigs were closed by editing,
custom primer walk or PCR amplification. Multiple sequence
alignments for phylogenetic tree analyses and recombination
analyses were constructed using MUSCLE (http://www.drive5.
com/muscle/) [32], with hand editing of difficult regions using
BioEdit (http://www.mbio.ncsu.edu/BioEdit/bioedit.html). Simi-
larity Plots were generated using SimPlot software (http://sray.
med.som.jhmi.edu/SCRoftware/simplot/) [33].
Genome annotation
Annotation of the assembled genome sequence was carried out
with the genome annotation system GenDB [34]. A combined
gene prediction strategy was applied by means of the GLIMMER
2.0 system and the CRITICA program suite [35] along with
postprocessing by the RBSfinder tool [36]. tRNA genes were
identified with tRNAscan-SE [37]. The deduced proteins were
functionally characterized by automated searches in public
databases, including SWISS-PROT and TrEMBL [38], Pfam
[39], TIGRFAM [40], InterPro [41], and KEGG [42]. Addition-
ally, SignalP [43], helix-turn-helix [44], and TMHMM [45] were
A1–A4 Complex Gene Analysis
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applied. Finally, each gene was functionally classified by assigning
clusters of orthologous groups (COG) number and corresponding
COG category [46] and gene ontology numbers [47].
Genomic comparison
The whole genome sequences of the C. botulinum type A1 strains were
deposited within the NCBI website and are available using accession
numbers CP000726 (ATCC 19397) and CP000727 (Hall), and the
sequence of ATCC 3502 was accessed at www.sanger.ac.uk/
Projects/C_botulinum/. Homology searches were conducted at
the nucleotide and amino acid sequence level using BLAST [48].
To obtain a list of orthologs from C. botulinum genomes, a perl script
that determines bidirectional best hits was written. For example,
genes g and h are considered orthologs if h is the best BLASTP hit
for g and vice versa. E values of #10215 were acceptable. A gene is
considered strain specific if it has no hits with an E value of 1025 or
less. The genome comparisons at the nucleotide level were carried out
with genome alignment tools, including MUMmer2 [49], NUCmer
[50], and the Artemis Comparison Tool (ACT) [51] (http://www.
sanger.ac.uk/Software/ACT/). Insertion sequence (IS) elements
were identified and classified by using the ISFinder database [52].
RESULTS
DNA preparations of two BoNT/A1 strains (Hall and ATCC
19397), the BoNT/A2 Kyoto-F strain, the BoNT/A3 Loch Maree
strain, the bivalent Ba4 657 strain, and the BoNT/B1 okra strain
were cloned and sequenced to determine the arrangement and
sequence variation within the toxin cluster genes and their flanking
regions. These strains represent the four known BoNT subtypes
within serotype A, plus the bivalent B (bvB) and B1 subtypes. The
sequence data analyzed consisted of full-length genomic sequences
(1 contig; 3.6–4.0 mb) for four strains (two BoNT/A1, BoNT/A3
and BoNT/B1 strains), 3 contigs (BoNT/Ba4 strain), or 16 contigs
(BoNT/A2 strain). The presence of small (10.5 kb) or large (149–
270 kb) plasmids were identified within some of the strains. These
plasmid contigs were determined to be circular due to the presence
of multiple clones containing sequence data from both the
beginning and end of the contig within the same clone. The toxin
cluster within the BoNT/A2 strain was identified in the middle of
a 985 kb contig. Because of the large size of this contig it is
assumed that the A2 toxin cluster resides within the chromosome
of this strain, similar to the A1 strains.
Gene Cluster Arrangements
Figure 1 illustrates the toxin cluster gene arrangements found
within the strains of the four different BoNT/A1-A4 and the
BoNT/B1 subtypes. The two BoNT/A1 strain gene arrangements
are the same for each other, the BoNT/B1 okra strain and the
published BoNT/A1 ATCC 3502 (Hall 174) genome. Within the
three BoNT/A1 strains, the nucleotide sequences of the toxin
cluster genes are identical for the 11.7 kb region that encodes
Hall Sanger 
ATCC 3502
CLB A1 
ATCC19397
CLC A1 
Hall
CLM A2
Kyoto-F
pCLK A3 
Loch Maree
pCLJ A4
pCLJ bvB
pCLD B1 
Okra
IS605’ LycA orf X3     orf X2    orf X1   IS6’ BotR         NTNH                           IS3’
LycA   orf X3    orf X2     orf X1   IS6’ p47                   BoNT/A4
Flagellin’ HA70 H HA33   BotR BoNT/B1       IS256’
ArsC   orf X3     orf X2   orf X1  IS6’ p47     LycA  ArsC
Flagellin   IS3’ HA70            HA17        HA33    BotR         NTNH BoNT/A1            IS3’
Flagellin   IS3’ HA70             HA17        HA33    BotR            NTNH          IS3’
Flagellin   IS3’ HA70             HA17        HA33    BotR         NTNH          IS3’
BoNT/bvB      IS256’
962           14             63                218           126 44                              2185         
508  300          782    294             514        95          14             63                      227            126                                   44      251    455
514        95                                   14             63                         227            126                    44                                  251    455
227           39                      14                1226                  300           16 44 1020    1617
1329                  884           39                      14 1230                 181            16                                  44 679
1554   14             63       227          162                               26                                         2780
96779bp1219          39 14 1313 205                    16 44 1659
1521 14 63 226           162                                   26         2791
Toxin Gene Cluster
BoNT/A1
BoNT/A1
BoNT/A2
BoNT/A3
    NTNH              
    NTNH              
NTNH              
    NTNH              
p47
BotR     
BotR     
HA33   HA70Flagellin’
Figure 1. Diagram illustrating the neurotoxin complex gene arrangements found within strains representing the four different BoNT/A1-A4 and
the BoNT/B1 subtypes of C. botulinum. The gene arrangements within the three BoNT/A1 strains are identical to each other and to the BoNT/B1
okra strain which includes the HA70, HA17, HA33, BotR, NTNH and BoNT genes. This arrangement is different from the three strains that represent the
BoNT/A2, BoNT/A3 and BoNT/A4 subtypes which contains the orfX3, orfX2, orfX1, BotR, p47, NTNH and BoNT genes. The BoNT/A4 complex is
connected by dashed lines to the BoNT/bvB complex to indicate its presence within the same plasmid yet separated by about 97 kb. Partial IS
elements (designated IS’) are indicated in green and identified by IS family designations. Genes flanking the toxin complex include the lycA, arsC or
flagellin genes. The presence of a partial flagellin gene is designated as flagellin’. Hypothetical proteins are indicated in black. Numbers indicate the
distances in nucleotides within intergenic regions.
doi:10.1371/journal.pone.0001271.g001
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HA70, HA17, HA33, BotR, NTNH, BoNT and their intergenic
regions. In addition, comparison of the entire nucleotide sequences
of BoNT/A1 Hall, ATCC 19397, and ATCC 3502 chromosomes
reveals these strains exhibit 99% nucleotide identity within their
entire 3.8 mb length. This high level of similarity within the toxin
clusters and the genome sequences illustrates the clonal nature of
these three BoNT/A1 strains. While these three BoNT/A1 strains
are very highly conserved, they can be differentiated using variable
number tandem repeat (VNTR) analysis [53].
Comparisons of the NTNH gene sequences within the BoNT/
A1 and BoNT/B subtypes revealed an area of recombination in
the middle of this gene. The sequence within the first half of the
BoNT/B NTNH gene is similar to the NTNH sequence within
the BoNT/A1 subtype; however midway or at approximately
1800 bp, an area of recombination occurs and the BoNT/B
NTNH gene sequence becomes more similar to the NTNH of the
BoNT/A2, BoNT/A3 or BoNT/A4 subtypes for the latter half of
the gene (Figure 2 and Table 1). Such recombination events have
been noted previously [54], not only with NTNH proteins from
serotype A and B strains, but also within NTNH genes associated
with bivalent Ab strains and strains having silent, or unexpressed,
BoNT/B genes designated as A1(B) strains [12].
The three strains that represent the BoNT/A2-A4 subtypes
have the same toxin complex gene arrangement that includes
orfX3, orfX2, orfX1, BotR, p47, NTNH and BoNT genes
(Figure 1). Pairwise comparisons of the proteins encoded by these
toxin cluster genes show that there is great similarity between the
BoNT/A2 and BoNT/A3 strains (Table 1). The amino acid
identities between these subtypes range from 91–97%, which
suggests a common origin for these two toxin clusters.
The toxin complex genes within the BoNT/A4 subtype vary in
their identity to the BoNT/A2 and BoNT/A3 complex genes.
With three of the BoNT/A4 cluster genes-NTNH, BotR and
orfX3- an amino acid identity of 91–94% to the BoNT/A3
subtype is observed. However, within the orfX1, orfX2, p47, and
BoNT only 75–88% identity is seen (Table 1). These differences in
identity among the proteins within the toxin cluster of BoNT/A4
when compared to the BoNT/A2 and BoNTA3 strains indicate
possible sites of genetic rearrangements or recombination events.
Insertion Sequences
The sequence coverage allowed a thorough examination of the
regions flanking the toxin complex genes to investigate possible
mechanisms of genetic mobilization of the toxin cluster genes.
Insertion sequence elements (IS elements) are short sequences of
DNA that encode transposase enzymes that promote their trans-
location and contribute to genetic recombination and exchange
among bacteria [55]. Table 2 lists the IS elements that were
identified and Figure 1 shows their location in relation to each of the
toxin gene clusters. Only partial IS elements, ranging from 23–83%
homology to the full length elements, were identified within the
intergenic or flanking regions of the toxin complex from each
subtype. These degraded IS elements were characterized by IS
family, group and closest IS homolog using the IS Finder database
[52]. The location and sequences of the IS elements provided insight
into the relationships among these subtypes.
In the three BoNT/A1 strains, partial IS elements were
identified, one element upstream and two downstream from the
toxin complex genes (Figure 1). The same location of these IS
elements among the three strains shows that these A1 strains share
a similar ancestor. Their degradation to 40%–79% of the full
length element suggests that significant evolutionary time has
occurred since their insertion into this region of the chromosome.
Although the BoNT/A1 and BoNT/B strains have similar
genes that comprise their toxin clusters, the IS elements that are
located upstream of the toxin complex genes differ in these two
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Figure 2. Simplot comparing the NTNH subtype sequences to the
Loch Maree strain. The NTNH genes within BoNT/A1, BoNT/A2, BoNT/
A4, BoNT/B1 and BoNT/bvB subtypes were compared to the NTNH gene
within the BoNT/A3, Loch Maree strain. The plot shows the similarity of
the NTNH genes within each of these subtypes along the length of the
gene and shows a recombination event in the middle of the A1 NTNH
gene (at approximately 1800 bp) where the sequence becomes more
similar to the A3 NTNH in the second half of the gene.
doi:10.1371/journal.pone.0001271.g002
Table 1. Comparison of amino acid identities between the
proteins within the toxin clusters.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Subtype HA70 HA17 HA33 BotR P47 NTNH BoNT
1ST half 2nd half
B1 vs bvB 96% 98% 84% 100% ----- 100% 100% 96%
bvB vs A1 98% 98% 97% 98% ----- 99% 67% 37%
orfX3 orfX2 orfX1 BotR P47 NTNH BoNT
1ST half 2nd half
A1 vs A2 ----- ----- ----- 61% ----- 62% 90% 90%
A2 vs A3 97% 95% 97% 91% 95% 96% 93% 93%
A3 vs A4 95% 78% 88% 91% 75% 91% 94% 84%
Percent amino acid identities between the different BoNT subtypes are shown
for each of the proteins within the toxin clusters. Amino acid identity among
the A1 and B1/bvB cluster proteins (HA70, HA17, HA33, BotR, and NTNH) ranges
from 83–100%. Comparison of the BoNTs in A1 versus B1 strains show only 37%
amino acid identity; the NTNH comparisons for BoNT/A1 vs B1 show that the
first half of the protein is similar while the second half is divergent. The amino
acid identity within the toxin cluster found among the BoNT/A2-A4 subtypes
ranges from 74–98%. Within the three subtypes the most similar proteins
appear to be NTNH, BotR, and orfX3 (92–98%), while the orfX1, orfX2, p47, and
the BoNT similarities range from 74–93%.
doi:10.1371/journal.pone.0001271.t001..
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serotypes. The IS element fragments in both the BoNT/B1 and
BoNT/bvB strain belong to the IS256 family and the BoNT/A1
IS element fragments are of the IS3 family, indicating independent
insertion events occurred within these two serotypes.
A partial IS element between the orfX1 and the BotR gene was
identified within the toxin complex genes of BoNT/A2, BoNT/A3
and BoNT/A4 subtypes (Figure 1). This partial element is in the
same location and orientation within all three subtypes where 68%
(BoNT/A2), 75% (BoNT/A3) or 83% (BoNT/A4) of the element
remains. The similar location of this partial IS element among the
A2, A3, and A4 subtypes supports a similar origin for these three
subtypes. Comparisons of the nucleotide sequence within
a common region of these partial IS elements of A2 versus A3,
A3 versus A4, and A2 versus A4 revealed identities of
approximately 98%, 90%, and 90% respectively. This suggests
that the BoNT/A2 and BoNT/A3 subtypes are more closely
related to each other than to the BoNT/A4 subtype.
Plasmids
The sequence analyses for each strain revealed the presence of
single plasmids within the BoNT/A3 Loch Maree strain, the
BoNT/B1 okra strain, and two plasmids within the bivalent Ba4
657 strain. The circular nature of the plasmid contigs was
confirmed by the presence of multiple clones containing sequence
data from both the beginning and the end of the contig in the same
clone. The plasmids are approximately 149 kb (pCLD within the
BoNT/B1 okra strain) 267 kb (pCLK within the BoNT/A3 Loch
Maree strain) and 270 kb (pCLJ within the bivalent Ba4 657
strain) and each were surprisingly found to contain the toxin
complex genes. The pCLJ within the bivalent Ba4 strain contains
both the BoNT/A4 and the BoNT/bvB toxin complex genes
separated by approximately 97 kb; neither of these toxin complex
genes was found within the chromosome. A second, smaller
(10.5 kb) plasmid within the bivalent Ba4 657 strain was also
identified that contains no toxin cluster genes.
Figure 3 shows a plasmid map and Table 3 describes the plasmid
features for each of the larger plasmids. These three plasmids contain
191–323 predicted coding regions, of which only 23–36% have
known functional properties. These plasmids do not contain rDNA
genes. They contain neither the E. coli plasmid-like rolling-circular
replication genes of repA, B, C nor the Bacillus anthracis plasmid-like
theta replication genes of repX, rep165, rep63A, repE, repS, and repR.
Although these plasmids appear to be capable of independent
replication, as they have complete DNA polymerase III complex
enzymes (including dnaN) and DNA helicase II (including pcrA) for
replication, their precise replication mechanism remains unclear.
Even though these three plasmids are of different sizes, they
share significant sequence homology. The overall plasmid synteny
of the three plasmids is compared in Figure 4. Sequence
comparisons between the two large plasmids within the BoNT/
A3 strain and the bivalent Ba4 strain illustrate the large regions
within the plasmids that are very similar to each other (about 96%
identity over 183 kb, which is 68% of the total length). Several of
these regions flank areas where the toxin gene clusters are found.
Regions that are not shared, for example where the BoNT/B1 and
BoNT/bvB cluster appears within the BoNT/A3 strain or the
BoNT/A3 and BoNT/A4 cluster appears within the BoNT/B1
strain, appear to have been deleted from the pCLK (BoNT/A3) or
pCLD (BoNT/B1) plasmids. The BoNT/A3 and BoNT/A4
cluster in pCLJ has been replaced by an approximately 14 kb
nonhomologous DNA fragment flanked by an intact IS element
(IS605) in pCLD. Insertion events that may have incorporated the
BoNT/A4 cluster within the bivalent plasmid and deletion events
within the BoNT/B1 plasmid likely explain the differences
observed in plasmid size, because the overall level of sequence
identity and synteny remain high within these two plasmids.
An inversion has occurred in the region of the BoNT/A3 and
BoNT/A4 plasmids that contains the toxin gene complex clusters.
This inversion involves a sequence of approximately 16.7 kb,
where the toxin gene cluster for BoNT/A4 appears in the opposite
direction from BoNT/A3. Examination of the sequences flanking
this region did not identify any palindromic or identical IS
elements in the BoNT/A4 gene cluster, to indicate a possible
mechanism for this event.
The identification of the BoNT/bvB and BoNT/A4 toxin
complex genes within the same plasmid provides the first
molecular characterization of these genes within a bivalent strain.
The BoNT proteins are produced in differing amounts in bivalent
Table 2. Insertion sequence (IS) elements identified within intergenic and flanking regions of serotype A and B strains.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Subtype Location1 Intergenic Space2 IS Family3 IS Group3 IS Homolog3 Present/Full-length4 %Present5
A1 upstream 963 IS3 IS150 IS 1233 82/177 46%
downstream 2185 IS3 IS150 ISSau2 210/521 40%
downstream 2185 IS3 IS150 IS 1069 216/272 79%
A2 orfX1/p21 1226 IS6 ISS1Z 234/340 68%
A3 upstream 1329 IS605 IS200 IS200S 56/151 37%
downstream 679 IS3 IS150 ISSau2 148/521 28%
orfX1/p21 1230 IS6 ISS1Z 254/340 75%
A4 orfX1/p21 1313 IS6 ISOur1 282/340 83%
bvB downstream 2791 IS256 ISCp1 94/383 25%
B1 downstream 2780 IS256 ISCp1 77/329 23%
1IS element location with respect to the toxin complex.
2Intergenic space (in nucleotides)
3IS family, group and homolog identified using the IS Finder database.
4The IS element showing greatest homology at the amino acid level using BLAST
5Amino acids present/amino acids of the full-length element
IS elements present within the intergenic or flanking regions of the toxin complex from each subtype were identified and characterized by IS family and group. Only
partial IS elements ranging from 23–83% homology to the full-length elements, were identified. The IS elements and their location are the same within the BoNT/A1
strains of ATCC 3502, ATCC 19397 and Hall but not shown.
doi:10.1371/journal.pone.0001271.t002..
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strains and in the Ba4 strain the relative amount of BoNT/B
produced is greater than BoNT/A4. However, it is now known
that the gene copy number for the toxin complex is the same.
Their location within this 270 kb plasmid separated by approx-
imately 97 kb would indicate independent expression and this may
explain the observed difference in BoNT/A4 and BoNT/bvB
protein levels. In BoNT/A1 strains the NTNH and BoNT genes
are positively regulated by BotR, a sigma transcription factor that
immediately precedes these genes [13]. This mechanism may be
the same with BoNT/bvB from bivalent strains but may not be the
case with BoNT/A4, where the BotR gene is more distant from
the BoNT gene and is transcribed in a different direction.
The toxin complex genes within the newly identified BoNT/A3
and BoNT/A4 subtypes were found within plasmids yet contain the
same toxin complex genes as the BoNT/A2 cluster located within
the chromosome. Similarly, the toxin complex arrangement within
the BoNT/B1 and BoNT/bvB plasmids is the same as that within
the BoNT/A1 subtypes, which is found within the chromosome.
These relationships illustrate that recombination and gene transfer
events have contributed to the diversity of genomic locations
observed for each of these two distinct toxin complex types (A2-A3-
A4, A1-B1-bvB) within these serotypes and subtypes.
Flanking regions
The regions flanking the toxin complex genes within the plasmids
and the chromosome were examined to further understand the
relationships among these subtypes. The flanking regions within
the plasmids contain patterns of nonhomologous regions just
upstream or downstream of the toxin gene clusters, followed by
areas of great homology further upstream and downstream within
the plasmids (Figure 4). Comparisons of the regions containing
the BoNT/A3 and BoNT/A4 gene clusters show that these two
toxin gene clusters are inverted relative to each other within
pCLK and pCLJ. In addition, there is a 21–23 kb region
downstream of the BoNT/A3 and upstream of the BoNT/A4
clusters that shows no homology. Beyond this toxin cluster-
nonhomologous region, homologous plasmid sequences flank the
BoNT/A3 and BoNT/A4 gene cluster. These same sequences
flank a 14 kb region within pCLD that does not include a toxin
gene cluster (Figure 4).
The upstream homologous regions in the BoNT/A3 and
BoNT/A4 cluster are approximately 15.5–17 kb in length, coding
for 24–28 genes including the prophage maintenance system killer
protein, DNA helicase II, PcrA, thermonuclease and other
hypothetical proteins. The downstream regions in the BoNT/A3
and BoNT/A4 cluster are approximately 23–24 kb in length,
coding for 16–20 genes including the K03111 single-strand DNA-
Table 3. Plasmid features of pCLD, pCLJ and pCLK.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Plasmid Features pCLD pCLJ pCLK
B1 okra Ba4 Loch Maree
Size (bp) 148,780 270,346 266,805
Coding sequence (bp) 118,215 222,681 215,214
Coding sequence (%) 79.5% 82.4% 80.7%
G+C content (%) 25.4% 25.6% 25.6%
Average orf size (bp) 619 737 666
CDSs, total 191 302 323
Number of genes with function prediction 44 108 94
Genes with function prediction (%) 23.0% 35.8%` 29.1%
Number of genes in COG 29 94 65
Genes in COG (percentage) 15.2% 31.1% 20.1%
These attributes are compared among the three plasmids and show that 80–
82% of the plasmid sequence contains orfs with only 23–36% of these
predicted proteins having functional properties.
doi:10.1371/journal.pone.0001271.t003..
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Figure 3. Circular plasmid maps of pCLK (Loch Maree), pCLJ (657), and pCLD (okra). These plasmid maps show the location of the neurotoxin gene
complexes within each of the plasmids and the predicted sites of gene transcription. The 266,805 bp pCLK contains the BoNT/A3 gene, the
270,346 bp pCLJ contains both the BoNT/A4 and BoNT/bvB genes separated by about 97 kb and the 148,780 bp pCLD contains the BoNT/B1 gene.
The data are described from the outermost circle to the innermost circle. Circles 1 and 2 show black bars to indicate predicted coding sequences on
the plus strand (circle 1) and minus strand (circle 2). Circle 3 and 4 indicate the BoNT cluster genes transcribed on the plus strand and minus strand
respectively. The colors used in circle 3 and 4 are the same as shown in Figure 1: NTNH and BoNT genes are red, orfX1, orfX2, orfX3 are dark blue, p47
is light blue, HA70, HA17 and HA33 are light purple and botR is orange. Circle 5 depicts the G+C content and the innermost purple circle shows the
GC skew (G2C/G+C) with tan values .1 and purple,1.
doi:10.1371/journal.pone.0001271.g003
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binding protein ssb, DNA polymerase III, DnaN, cell wall-
associated biofilm protein and other hypothetical proteins.
The inversion that encompasses the BoNT/A3 and BoNT/A4
complexes includes the toxin complex genes and the lycA gene that
is upstream of both complex clusters. The lycA gene encodes
autolytic lysozyme (1,4-beta-N-acetylmuramidase). This gene is
also found downstream within the BoNT/A2 strain (Figure 1), but
not within either the chromosome or plasmid of the BoNT/B1
strain. The similar location of the lycA gene within the BoNT/A3
and BoNT/A4 strains and the overall plasmid synteny distinguish
these subtypes from the BoNT/A2 subtype.
The BoNT/B1 and BoNT/bvB toxin clusters within pCLD and
pCLJ are nearly identical but this toxin gene cluster is deleted in
pCLK. Instead this region in pCLK contains an intact flagellin
gene where only partial flagellin genes are located within both
pCLD and pCLJ (Figure 4). The BoNT/B1 and BoNT/bvB
cluster and nonhomologous region in pCLK is flanked upstream
and downstream by homologous regions of approximately 3500
and 9400 bp, respectively (Figure 4). The upstream region of nine
orfs includes DNA methylase transferase and the downstream
region orfs encode for RNA polymerase alpha subunit (RpoA),
stage III sporulation protein D (Sp3D), phage shock protein A
(PspA) and other hypothetical proteins.
The flanking regions of the complexes of BoNT/A1, BoNT/B1
and BoNT/bvB all have similar components of a partial or intact
flagellin gene, and the same three hypothetical proteins (Figure 1
and Figure 4). An intact flagellin gene can be found upstream of
the BoNT complex in the three BoNT/A1 strains (Figure 1) and in
the nonhomologous region of pCLK (Figure 4). Partial flagellin
genes are located downstream of the BoNT/B1 and BoNT/bvB
complexes. Three hypothetical proteins are upstream from the
intact flagellin gene in the three BoNT/A1 strains and are the
same hypothetical genes flanking the BoNT/B1 and BoNT/bvB
complex. Two of these hypothetical proteins are located in the
nonhomologous region within pCLK (Figure 4). The presence of
these sequences near the complexes of BoNT/A1, BoNT/B1 and
BoNT/bvB but distant to the BoNT/A3 and BoNT/A4 complex
link these subtypes and serotypes to a similar origin and distinguish
them from the BoNT/A2 strain where none of these sequences
have yet been identified. Instead the chromosomally-located
BoNT/A2 and plasmid-located BoNT/A3 and BoNT/A4 cluster
are all flanked by the lycA gene, and the BoNT/A2 cluster is
further flanked upstream and downstream by intact copies of the
arsC gene, which encodes arsenate reductase. This arsC gene was
not identified within the flanking regions of the other strains. The
location of duplicate copies of the arsC gene in the regions flanking
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Figure 4. Plasmid synteny among pCLK (Loch Maree), pCLJ(657) and pCLD (okra). The upper panel illustrates regions of similarity (indicated in red)
shared among these three plasmids. Regions that are not shared include the BoNT/B1 or BoNT/bvB gene clusters within the BoNT/A3 Loch Maree
strain or the BoNT/A3 and BoNT/A4 gene clusters within the BoNT/B1 okra strain. These regions appear to have been deleted from pCLK and pCLD.
Within pCLK and pCLJ an inversion, approximately 16.7 kb in size, has occurred where the toxin gene cluster for BoNT/A4 appears in the opposite
direction from BoNT/A3. The lower panel expands the two regions designated as insert 1 and 2 in the upper panel. These regions detail the
conserved plasmid sequences that flank the BoNT/A3 and BoNT/A4 extended cluster (15.4 kb upstream to 23.6 kb downstream) and the BoNT/B1
and BoNT/bvB extended cluster (3.5 kb upstream to 9.3 kb downstream).
doi:10.1371/journal.pone.0001271.g004
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the toxin complex could allow the formation of hairpin structures
that mediate recombination or movement of the toxin cluster
genes within the genome.
DISCUSSION
Sequences of eight botulinum toxin gene clusters from seven C.
botulinum strains were analyzed to determine the arrangement of
the toxin cluster genes in strains representing the BoNT/A1-A4
and BoNT/B1 subtypes, including a bivalent Ba4 strain. The
genomic sequence data provided information about the arrange-
ment of these toxin complex genes within these strains, the
presence of partial IS elements within intergenic and flanking
regions, and the location of these genes within the chromosome or
within a plasmid.
In these seven C. botulinum strains there are two distinct
arrangements of the toxin complex genes. The BoNT/A2,
BoNT/A3 and BoNT/A4 gene clusters contain polycistronic
orfX3, orfX2, orfX1, BotR, p47, NTNH, and BoNT genes. The
other arrangement found within the BoNT/A1, BoNT/B1, and
BoNT/bvB gene clusters contains HA70, HA17, HA33, BotR,
NTNH and BoNT genes. These two very different arrangements
of the toxin cluster genes are highly conserved even though they
exist in very different genomic backgrounds, and illustrates the
functional role each of these genes must have in the expression,
protection or transport of the neurotoxin.
BoNT/A1, BoNT/B1, and BoNT/bvB complex genes show
a high degree of relatedness. Amino acid identity among the
nontoxin cluster proteins (HA70, HA17, HA33, BotR, and
NTNH) ranges from 83–100%. However, comparisons of the
BoNT protein of BoNT/A1 to BoNT/B1 strains show only 37%
amino acid identity. The differences between these BoNT genes
and their associated toxin complex genes indicate that recombi-
nation events have contributed to the diversity between these
serotypes. Examination of NTNH sequences from various BoNT/
A and BoNT/B strains has identified a recombination ‘hot spot’’
occurring midway in the gene [3]. In these strains a recombination
event was also identified midway within the BoNT/A1 NTNH
gene resulting in a high degree of similarity to the BoNT/B1 and
BoNT/bvB NTNH gene within the first half of the gene and
greater similarity to the BoNT/A2, BoNT/A3 or BoNT/A4
NTNH in the latter half of the gene.
The similarity within the arrangements of the toxin complex
genes, their amino acid sequences and the presence of similar
proteins and partial IS elements in their flanking regions suggest that
the BoNT/A1, BoNT/B1, and BoNT/bvB clusters are from
a common lineage but mutation and/or recombination events have
contributed to their evolution as distinct serotypes and subtypes.
The other conserved gene cluster arrangement is found among
the BoNT/A2-A4 subtypes. In these subtypes, amino acid identity
within the cluster genes ranges from 74–98%. Within the three
subtypes the most similar proteins appear to be NTNH, BotR, and
orfX3 (92–98%), while the orfX1, orfX2, p47, and the BoNT
similarities range from 74–93%. The similar gene arrangement
and location of a partial IS element belonging to the IS6 family,
between BotR and orfX1 in these three subtypes also suggests
a common ancestry. This partial IS element and the amino acid
identities within the toxin complex proteins show that the BoNT/
A2 and BoNT/A3 gene clusters are more similar to each other
than to the BoNT/A4.
These BoNT/A2-A4 subtypes exhibit a complex history of
recombination. Recombination events include an inversion of the
entire BoNT/A3 and BoNT/A4 complex within a plasmid
background, relocation of the lycA gene in the chromosomal
flanking region of the BoNT/A2 subtype, the presence of different
flanking regions containing different partial IS elements, and
multiple gene duplication events involving the arsC gene that
resides both upstream and downstream of the BoNT/A2 cluster.
The presence of partial IS elements in flanking regions and/or
within the toxin gene clusters suggests that these mobile elements may
have had a role in the transfer of these genes during the evolution of
clostridial species [15,56]. IS elements, which can contribute to gene
mobility, flank the toxin gene clusters within the BoNT/A1 and
BoNT/A3 strains, and are found downstream of the clusters in the
BoNT/B strains. Their degradation to 23–83% of their original
length suggests that their insertion occurred early during the evolution
of C. botulinum. Since this time, paired IS elements could have been
lost and host genetic preferences (G+C content, di-nucleotide
frequency, codon bias) could have been acquired which might mask
evidence of earlier gene transfer events [57].
The presence of the toxin cluster genes within plasmids appears
just as common as their presence within the chromosome. In these
serotype A and B strains the BoNT/A1-B1-bvB complex can be
found within the plasmid or the chromosome. Similarly the
BoNT/A2-A3-A4 complex can be found in both locations. There
is no clear evidence to support whether the genes within these
toxin complexes originated within the chromosome or plasmid,
however the discovery of BoNT-encoding plasmids provides
insight into understanding the amount of apparent recombination
and movement of these genes among clostridial species. Earlier
reports of a chromosomal location for the toxin cluster genes from
serotypes A, B, E, and F were based on experiments using
techniques for the isolation of relatively small plasmids from
genomic DNA preparations [58]. Using pulsed-field gel electro-
phoresis and Southern hybridization techniques the presence of
the BoNT/A3, BoNT/A4 and BoNT/bvB genes within plasmids
has recently been confirmed [59]. Here the presence of plasmids
was discovered after genomic sequencing of these strains. These
findings suggest that other plasmids may exist within C. botulinum
strains.
Sequence comparisons show that these plasmids appear to be
unique. They have no similarity to the toxin-encoding plasmids
within C. tetani [56], C. perfringens [60], or the BoNT/C and BoNT/
D-encoding phage within C. botulinum [61]. Other neurotoxin-
encoding plasmids identified within C. botulinum are found within the
serotype G strains [62]. Since none of these BoNT/G containing
plasmids have yet been sequenced it is unknown whether these share
any similarity to pCLD, pCLJ or pCLK. Although the exact
mechanism of their replication is not understood, these large
plasmids appear to be in low copy number based on the relative
sequence coverage of the plasmid and chromosome. Their presence
and/or expression of BoNT must confer an advantage to the host to
have been maintained in these strains.
Whether within a plasmid or chromosome, all of the strains
(except the BoNT/A2 strain) share flanking regions encoding two
or three hypothetical proteins and an intact or partial flagellin
gene. This relationship suggests a common ancestor that may have
contained these sequences within a plasmid, phage or chromo-
some. In pCLK an intact flagellin gene and two of the three
hypothetical proteins are located in a region distant to the BoNT/
A3. This region contains homologous plasmid sequences both
upstream and downstream and suggests a toxin gene could have
been deleted in this region of the plasmid that contains the BoNT/
B1 or BoNT/bvB cluster in pCLJ or pCLD.
The identification of both the BoNT/bvB and BoNT/A4 toxin
gene clusters within the same plasmid in the Ba4 strain provides an
example of two distinct toxin clusters located within one bivalent
strain and provides insight into the possible nature of other
bivalent strains. Their presence within the same plasmid having
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the same copy number within the cell cannot explain the different
levels of BoNT/bvB and BoNT/A4 produced in relation to each
other. The two gene clusters are distant from each other and likely
controlled via different regulatory systems, resulting in differing
toxin expression levels.
These analyses of genomic sequence data elucidate some of the
mechanisms active within the C. botulinum family that have resulted
in a surprising range of genetic diversity within the few proteins
that make up the BoNT cluster. Genomic sequencing has
identified the arrangement of the toxin complex genes in these
strains, characterized their intergenic and flanking sequences,
identified recombination events and revealed the presence of
neurotoxin-containing plasmids in three of these strains. With the
exception of BoNT/A4, the neurotoxins produced in these strains
show equivalent toxicity regardless of toxin gene, or gene cluster
arrangement or location. The gene cluster arrangements appear to
have successfully evolved to allow the survival and expression of
different BoNTs within these organisms. Their movement into
different genetic backgrounds including different species may be
mediated by the presence of IS elements, duplicated genes flanking
the toxin complex, and the presence of the toxin genes within
plasmids. This has resulted in a surprising amount of diversity
within the many bacterial strains that comprise C. botulinum.
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